Interdisciplinary Team

Subhawana Subba is an Associate Scientist I in the Bioanalytical Sciences group. She holds a Master of Science in Biotechnology from Northeastern University in Boston. Previously, Subhawana worked as a bioanalytical co-op at Strand. She has worked as a graduate student researcher at Dr. Amiji’s lab at Northeastern University on the oral gene delivery project. She has a Bachelor of Engineering in Biotechnology and transitioned from her role as an R&D Associate in sustainable agriculture to pursue her passion for innovative science that improves patient health and quality of life.

Sushmit is an Associate Scientist in Strand Therapeutics’ mRNA Process Development Team, focusing on mRNA production and process optimization. He holds a Bachelor’s degree in Pharmacy from the University of Mumbai and a Master of Science in Pharmaceutical Sciences with a concentration in Pharmaceutics and Drug Delivery from Northeastern University, Boston. His background includes significant experience at Moderna in their RNA Process Development team, where he developed next-generation processes and improved process robustness. Sushmit has over two years of experience in Downstream Process Development and Purification and is committed to leveraging his skills and experience to drive innovation and efficiency in mRNA production at Strand Therapeutics.

Weiyu is a Principal Scientist in the LNP discovery group at Strand Therapeutics. Her research expertise involves the development of functional drug/gene delivery systems. Weiyu received her Ph.D. in Pharmaceutical Sciences from the Ohio State University, where she worked on developing lipid nanoparticles for mRNA based therapeutics. She also holds an M.S. degree in Pharmaceutics and a B.S. degree in Pharmacy from Peking University Health Science Center. Weiyu has authored and co-authored peer-reviewed publications in journals, such as Nature Nanotechnology, Nature Cancer, Nature Biomedical Engineering, Science Advances, and Chemical Science and Biomaterials.

Wuhbet is a Manager of In Vivo Discovery at Strand Therapeutics. She is an experienced researcher with a demonstrated history of contributing to the development of novel vaccine platforms. Her primary focus as a former member of the Irvine Lab in the Koch Institute at MIT was targeted and temporally controlled delivery of cancer immunotherapies and HIV vaccines. Her background includes extensive experience as Environmental Health and Safety personnel to ensure compliance of lab practices, a certificate in Biomedical Laboratory Sciences from Boston University, and B.S. in Biology from University Of Asmara.

Zach Webb is an Associate Scientist of Process Development and he is working cross-functionally to support mRNA production and LNP Formulation scale up efforts. Zach completed his B.S. in Biochemistry at Northeastern University in 2023. During his time at Northeastern he completed two co-ops in process development, one at Wave Life Sciences and the second here at Strand.

Zhijun Su is a Principal Associate Scientist at Strand Therapeutics. She is currently supporting Strand’s cancer immunotherapy program. She is adept at RNA synthesis, immunological analyses, running mouse models, and keeping the lab organized. Prior to Strand, she worked at Koch Institute of Integrative Cancer Research at MIT, Irvine Lab, where she worked on a number of mouse animal studies, and supported cell culture and molecular biology experiments. She earned her B.S. in Biochemistry and Molecular Biology from the University of Massachusetts Amherst.